Related references
Note: Only part of the references are listed.Oral saquinavir mesylate solid dispersions: In vitro dissolution, Caco-2 cell model permeability and in vivo absorption studies
Thiago Caon et al.
POWDER TECHNOLOGY (2015)
Development and physicochemical characterization of saquinavir mesylate solid dispersions using Gelucire 44/14 or PEG 4000 as carrier
Thiago Caon et al.
ARCHIVES OF PHARMACAL RESEARCH (2013)
Lipid-based formulations for oral administration of poorly water-soluble drugs
Huiling Mu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS)
N. Thomas et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs
Arik Dahan et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Preclinical formulations for discovery and toxicology: physicochemical challenges
Seshadri Neervannan
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Factors responsible for the variability of saquinavir absorption: Studies using an instrumented dog model
N Tam-Zaman et al.
PHARMACEUTICAL RESEARCH (2004)
High variability of plasma drug concentrations in dual protease inhibitor regimens
JB Guiard-Schmid et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems
CW Pouton
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2000)
Share Paper
